ML-004

· MapLight Therapeutics

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ML-004, covering 2025-12-22 to 2026-03-16. Get the full timeline:

Most recent: Clinical Trial Update: ML-004 Open-Label Extension Study in Adults and Adolescents With Autism Spectrum Disorders (ASD) [Phase 2]